Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02608619 · ClinicalTrials.gov registry record
Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 3
- Enrollment target
NCT02608619: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02608619 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02608619 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The main purpose of this study is to discover how 18F-cholineFCH distributes in the body, and see if it can distinguish active histiocytes (tumor) from inflammatory (non- tumor) cells. This tracer has the potential to give the investigators' team more information when trying to identify the tumor cells that are most important to collect with biopsy. In addition, the study will measure levels of 18F-cholineFCH in the biopsy tissue.
Primary Outcome
The overall histiocyte content will be described in each patient for each paired biopsy: there will be one biopsy that has high 18F-FCH F-choline uptake and one biopsy that has low 18F-FCH F-choline uptake.
Interventions
- PROCEDURE biopsy
- DEVICE FDG-PET
- RADIATION F-choline PET Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-08 |
What the finished NCT02608619 record still lists
NCT02608619 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which biopsy is the first listed.
NCT02608619 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02608619 about?
NCT02608619 is a clinical study titled "Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement". The main purpose of this study is to discover how 18F-cholineFCH distributes in the body, and see if it can distinguish active histiocytes (tumor) from inflammatory (non- tumor) cells. This tracer has the potential to give the investigators' team more information when trying to identify the tumor ce...
What is the current status of trial NCT02608619?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2015-11. Estimated completion is 2018-08.
What interventions are being tested in trial NCT02608619?
The interventions under investigation include: biopsy (PROCEDURE), FDG-PET (DEVICE), F-choline PET Scan (RADIATION).
Who is sponsoring clinical trial NCT02608619?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia